Get startedLog in
    Picture of Regulus Therapeutics logo

    RGLS — Regulus Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Regulus Therapeutics Announces FDA Acceptance Of IND Application For RGLS8429 For Treatment Of ADPKD

    Picture of Regulus Therapeutics logoRegulus Therapeutics
    11/05/2022 13:18
    May 11 (Reuters) - Regulus Therapeutics Inc  RGLS.O :
    * REGULUS THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF
INVESTIGATIONAL
NEW DRUG (IND) APPLICATION FOR RGLS8429 FOR THE TREATMENT OF
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    * REGULUS THERAPEUTICS INC - COMPANY REMAINS ON TRACK TO
INITIATE
PHASE 1 CLINICAL STUDY IN Q2 2022

Source text for Eikon:  ID:nPn2B5MV7a 
Further company coverage:  RGLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Regulus Therapeutics

    See all news